IGF2BP1 and hepatocellular carcinoma: Mechanistically, ALDOA interacts with IGF2BP1 to promote the expression of eIF4G by accelerating IGF2BP1 binding to m6A‐modified eIF4G mRNA, thereby augmenting oncogenic mRNA translation in HCC.